Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.
Related Posts
How to Be Less Self-Critical When Perfectionism Is a Trap
Yuxin Sun, a psychologist in Seattle, sees a lot of clients at her group practice who insist they aren’t perfectionists.…
Tiny Coffins: Measles Is Killing Thousands of Children in Congo
Problems with getting vaccines to families have left many children unvaccinated and in danger of contracting the virus.
Teen Drug Use Habits Are Changing, For the Good. With Caveats.
Historically speaking, it’s not a bad time to be the liver of a teenager. Or the lungs. Regular use of…